AI Could End Disease in a Decade, Says Google DeepMind CEO

 

Google DeepMind CEO Demis Hassabis predicts that AI could eradicate disease within the next decade by revolutionizing drug development, slashing timelines from years to weeks. In a 60 Minutes interview on April 22, 2025, the Nobel Prize-winning AI researcher also forecasted artificial general intelligence (AGI) in 5-10 years and humanoid robot breakthroughs within two years. However, he noted that current AI lacks imagination, limiting its ability to generate novel ideas.

AI’s Healthcare Revolution

Hassabis highlighted AI’s potential to transform drug discovery. “It takes 10 years and billions of dollars to design one drug. We can reduce that to months or weeks,” he said. His work on AlphaFold, which predicts protein structures, earned him the 2024 Nobel Prize in Chemistry and is accelerating treatments for diseases like cancer. This could make the end of disease a reality by 2035.

AGI and Robotics: The Next Frontier

Hassabis predicted AGI—AI with human-level cognition—within 5-10 years. Yet, he cautioned that AI lacks creativity: “It can’t yet ask novel questions or form new hypotheses.” He also foresaw humanoid robots performing useful tasks within two years, transforming industries.

Hassabis’s Vision

A neuroscientist and computer scientist, Hassabis co-founded DeepMind, acquired by Google in 2014. His pragmatic approach prioritizes building intelligent tools over debating AI consciousness.

Why This Matters for the Future

Hassabis’s predictions paint a picture of a world on the cusp of transformative change. From AGI to humanoid robots to the eradication of disease, AI is poised to redefine what’s possible. However, his acknowledgment of AI’s limitations—particularly its lack of imagination serves as a reminder that significant challenges remain. Bridging the imagination gap will require not only technical breakthroughs but also a deeper understanding of human cognition, an area where Hassabis’s neuroscience background gives him a unique edge.

For businesses, researchers, and policymakers, these developments signal the need to prepare for a rapidly evolving landscape. The potential to reduce drug development timelines, deploy intelligent robots, and achieve AGI within a decade offers immense opportunities but also raises ethical and societal questions. Hassabis’s call to prioritize intelligent tools over speculative concerns like AI consciousness provides a roadmap for responsible innovation.

Conclusion

From ending disease to pioneering AGI and robotics, AI is reshaping the future. Demis Hassabis’s insights offer a glimpse into an AI-driven future that’s both thrilling and grounded in practical realities. While AGI may be five to ten years away, the immediate impact of AI in healthcare and robotics is already taking shape. With breakthroughs like AlphaFold and the promise of humanoid robots on the horizon, Google DeepMind is leading the charge toward a world where AI not only augments human capabilities but also tackles some of humanity’s greatest challenges. Hassabis’s insights show how tools like AlphaFold are paving the way for a healthier, smarter world.